Condition
Spinocerebellar Ataxia Type 27B
Total Trials
2
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
5 treatments under study, led by Genetic Testing
Research Leaders
20 sponsors active, led by University of Washington
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Clinical Trials (2)
Research Network
Common Treatments
- Genetic Testing1
- Cerebrospinal Fluid Collection1
- Magnetic Resonance Imaging Mri Scan1
- Assessments And Questionnaires1
- Blood Collection1
Active Sponsors
- University of Washington1
- University of California, San Francisco1
- University of Texas Southwestern Medical Center1
- University of Pennsylvania1
- Massachusetts General Hospital1
Top Investigators
University Hospital Tuebingen
Columbia University
University of Texas
University Hospital Tuebingen
Johns Hopkins University
Related Conditions
- Healthy Participants1
- Spinocerebellar Ataxia Type 11
- Rfc1 Gene Mutation1
- Spinocerebellar Ataxia Type 71
- Spinocerebellar Ataxia Type 81